A detailed history of Group One Trading, L.P. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 100 shares of FLGT stock, worth $2,291. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 1,799 94.44%
Holding current value
$2,291
Previous $39,000 97.44%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$19.09 - $22.57 $32,433 - $38,346
-1,699 Reduced 94.44%
100 $1,000
Q1 2024

May 10, 2024

SELL
$21.55 - $29.29 $18,252 - $24,808
-847 Reduced 32.01%
1,799 $39,000
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $59,667 - $76,401
2,524 Added 2068.85%
2,646 $76,000
Q3 2023

Nov 09, 2023

SELL
$26.74 - $40.81 $139,743 - $213,273
-5,226 Reduced 97.72%
122 $3,000
Q2 2023

Aug 09, 2023

BUY
$28.52 - $40.7 $75,834 - $108,221
2,659 Added 98.88%
5,348 $198,000
Q1 2023

May 12, 2023

BUY
$29.39 - $36.27 $45,554 - $56,218
1,550 Added 136.08%
2,689 $83,000
Q4 2022

Feb 09, 2023

BUY
$29.23 - $40.28 $33,292 - $45,878
1,139 New
1,139 $33,000
Q2 2022

Aug 11, 2022

BUY
$47.98 - $62.75 $51,338 - $67,142
1,070 Added 30.33%
4,598 $251,000
Q1 2022

May 12, 2022

BUY
$49.85 - $96.11 $175,870 - $339,076
3,528 New
3,528 $220,000
Q3 2021

Nov 12, 2021

SELL
$74.87 - $110.87 $1.04 Million - $1.53 Million
-13,826 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$66.8 - $100.45 $923,576 - $1.39 Million
13,826 New
13,826 $1.28 Million
Q1 2021

May 12, 2021

SELL
$59.3 - $183.85 $1.39 Million - $4.31 Million
-23,439 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$31.01 - $52.1 $152,910 - $256,905
4,931 Added 26.64%
23,439 $1.22 Million
Q3 2020

Nov 12, 2020

BUY
$15.89 - $50.51 $294,092 - $934,839
18,508 New
18,508 $741,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $693M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.